Nocil Ltd. Share Price

Profit Grows 61% - NOCIL Ltd

Code BSE: 500730 NSE:

The Company has separately announced a further Rs 130 crore brownfield capital expenditure programme at its Dahej facility, aimed at expanding capacity for peak-utilisation rubber chemical products through an integrated, backward-integrated facility. This is in addition to the Rs 250 crore capex programme already underway at Dahej, which has moved into trial production.

See More

Gets Competitive Boost from Five-Year Anti-Dumping Duty

The Government of India has imposed a five-year anti-dumping duty (ADD) on imports of sulphenamides accelerators originating from China, the European Union, and the United States. This regulatory move strongly boosted market sentiment for

, driving an "Overweight" rating from analysts. Core Product Impact: Sulphenamides (including CBS, TBBS, and MBS) are essential rubber chemicals used to control the speed and temperature of the sulfur vulcanization curing process. These accelerators are a vital component of the company's portfolio, making up 45% of its total product mix under the Pilcure brand. Combating Cheap Imports: As the leading domestic manufacturer holding a market share of over 50%, the company was highly vulnerable to foreign dumping. An investigation by the Directorate General of Trade Remedies (DGTR) revealed massive injury margins ranging from 10% to 60%, with price undercutting between 10% and 20% primarily driven by China, which accounts for over 80% of these imports. Margin and Revenue Boost: The new ADD of $974 per tonne on Chinese imports is estimated to elevate their landed value by roughly 34%. This protection provides a significant upside for the company’s domestic accelerators business, which previously operated on low single-digit margins, and is expected to raise capacity utilization beyond its current 70% level. Strategic Growth Triggers: Beyond domestic protection, the company's financial outlook is supported by a positive export environment due to US tariff relaxations. Furthermore, medium-term growth is secured by a commissioned ₹250-crore antioxidant plant entering commercial production by H2 FY27, alongside a newly announced ₹130-crore backward integration project slated for H1 FY28

See More

NOCIL Ltd – Fundamental Analysis

NOCIL Ltd is India’s largest manufacturer of rubber chemicals, supplying products used primarily in the tyre industry as well as other rubber-based applications. The company manufactures a wide range of rubber chemicals including antidegradants, accelerators, and specialty chemicals that enhance the performance, durability, and safety of tyres and industrial rubber products. The company benefits from its strategic role in the automotive value chain, as demand for rubber chemicals is closely linked to tyre production and replacement demand. Growth in vehicle ownership, infrastructure development, logistics activity, and replacement tyre demand in India provide long-term growth opportunities. Financially, NOCIL has maintained a relatively strong balance sheet with low debt levels and healthy operational capabilities. The company has invested significantly in expanding manufacturing capacity over the years, positioning itself to meet future demand growth. One of NOCIL’s major strengths is its leadership position in a specialized segment where technical expertise, product quality, and regulatory approvals create entry barriers. The company also benefits from import substitution opportunities as Indian manufacturers increasingly source chemicals domestically. However, investors should monitor fluctuations in crude oil-derived raw material costs, global competition, demand trends in the automotive sector, and margin volatility. Since the company serves a cyclical industry, earnings can be affected by slowdowns in vehicle production or weaker industrial activity. Overall, NOCIL Ltd appears to be a fundamentally strong specialty chemical company with market leadership, strong manufacturing capabilities, and exposure to India's growing automotive and tyre sectors.

See More

NOCIL Ltd (NSE: NOCIL) – SWOT Analysis

S – Strengths ✅ 1. Market leadership in rubber chemicals NOCIL has a strong position in India's rubber chemical industry with established customer relationships. 2. Debt-free balance sheet Company has maintained a low financial risk profile with near-zero debt, giving flexibility during industry cycles. 3. Strong product portfolio Manufactures accelerators, antioxidants and specialty rubber chemicals used in tyres, automotive and rubber products. 4. China+1 opportunity Global customers looking beyond China suppliers can create opportunities for Indian rubber chemical manufacturers. W – Weaknesses ⚠️ 1. Margin pressure Profitability has been impacted by weak demand, pricing pressure and higher competition. 2. Lower return ratios ROE/ROCE have remained under pressure compared with high-quality specialty chemical companies. 3. Limited diversification Business is heavily linked to rubber chemicals and tyre industry cycles. 4. Growth slowdown Revenue and profit growth have faced challenges in recent periods. O – Opportunities 🚀 1. Automotive & tyre growth Growth in Indian automobile production, EV tyres and replacement tyre demand can support long-term demand. 2. Export expansion NOCIL can benefit from increasing global sourcing from India. 3. Premium specialty chemicals Higher-value rubber chemicals for heat resistance and durability can improve product mix. 4. Capacity expansion Additional capacity can support future volume growth if demand improves. T – Threats ⚠️ 1. Chinese competition Excess capacity from China and aggressive pricing can hurt margins. 2. Raw material volatility Chemical input prices can impact profitability. If earnings recovery is slow, high valuation multiples can limit upside. Investor View (Long Term) Positive Factors: ✔ Market leader ✔ Debt-free company ✔ China+1 opportunity ✔ Tyre sector growth potential Risk Factors: ❌ Margin recovery is key ❌ Chinese dumping risk ❌ Profit growth needs improvement

See More

NOCIL: Rally Hype or Real Value for Shareholders?

NOCIL, a mid‑sized specialty‑chemical maker, has seen its stock touch fresh highs even as broader markets stay volatile. The surge is being driven by re‑rating flows into the Indian specialty‑chemical space, where investors expect steady demand from agrochemicals, polymers, and industrial segments over the long term. The company’s niche product portfolio and export‑linked earnings are seen as a hedge against domestic cyclicality, which has helped sentiment lift the share price off recent 52‑week levels. From a shareholder perspective, the run‑up is a double‑edged story. On the positive side, higher valuations unlock better capital‑raising options for the company, strengthen its takeover or consolidation appeal, and compress the cost of equity for future growth capex. For existing long‑term holders, the move offers a partial exit window or a chance to compound further if fundamentals genuinely improve. However, the stock’s recent performance has not been fully matched by earnings quality: NOCIL’s sales growth has been modest, return on equity remains low, and net margins have compressed versus recent highs, suggesting that part of the rally is more sentiment‑driven than factor‑driven. For new investors, chasing the current price may carry risk if earnings fail to accelerate. The specialty‑chemical cycle is notoriously earnings‑volatile, and NOCIL’s promoter holding is also not very high, which implies less skin‑in‑the‑game versus some peers. On the flip side, the company’s balance sheet is relatively clean and its debt profile is manageable, so a pullback could be a better entry point for patients shareholders who believe the sector thesis will play out over the next few years. Overall, the current upswing is beneficial for existing holders who can selectively book profits, but new positions should be scaled in only after a meaningful correction and closer scrutiny of margins, order book visibility, and capex returns.

See More